Will Regular Screening of Men with Genetic Mutations for PSA Lead to Better Prostate Cancer Diagnoses?
Dr. John S. Witte spoke at the 25th International Prostate Cancer Update on Thursday, January 22,...
Read MoreSelect Page
John S. Witte, PhD, earned his master’s degree from the University of California, Berkeley, and a PhD in epidemiology from the University of California, Los Angeles. After receiving his degree in Los Angeles, he was an Assistant Professor of Preventive Medicine at the University of Southern California.
Dr. Witte joined the UCSF departments of Epidemiology & Biostatistics and Urology from Case Western Reserve University School of Medicine in Cleveland, Ohio. At Case, Witte was honored with a teaching award, the 1999-2000 Glennan Fellowship, given for innovation in teaching and education. He was honored again in 2002-2003 with the Visiting Scientist award from the International Agency for Research on Cancer in Lyon, France.
Dr. Witte’s research program constitutes applied and methodological genetic epidemiology, with the overall aim of deciphering the mechanisms underlying complex diseases. His applied work is focused on prostate cancer, and complements other work done at the UCSF Prostate Cancer Center.
Dr. Witte’s genetic epidemiology studies examine the genetic basis of prostate cancer, and have included searches across the human genome and work on specific candidate genes. Successes have included the isolation of distinct chromosomal regions that appear to harbor prostate cancer causing genes, and the first genome-wide scan for genes linked to the aggressiveness of prostate cancer.
Dr. Witte's research constitutes applied and methodologic genetic epidemiology, with the overall aim of deciphering the mechanisms underlying complex diseases. At present, his applied work is primarily focused on prostate cancer, while much of his methodologic work is on hierarchical modeling and association studies.
Posted by John S. Witte, PhD | Mar 2015
Dr. John S. Witte spoke at the 25th International Prostate Cancer Update on Thursday, January 22,...
Read More